Hopital Shriners Inc

Details
Medical Suppliers In Quebec

Name :

Hopital Shriners Inc

Address  :

1529 Cedar Avenue

Town  :

Montreal

State  :

Quebec

Country  :

CANADA

Post Code:

H3G 1A6

Phone  :

514 842 4464

Fax  :

514 842 7553

Web URL  :

Available
Specialization
  • Anaesthesiology
  • Neuro Surgeon
  • Neurologist
  • Orthopedics
  • Paediatrics
  • Plastic Surgery
  • Urology
Facilities

Total Number Of Beds : 40

Description
Shriners Hospitals for Childrenreg Canada is a 40bed pediatric orthopedic hospital research and teaching center providing comprehensive medical surgical and rehabilitative care to children with orthopaedic conditions

The hospital is staffed and equipped to deal most pediatric orthopaedic conditions except for acute trauma

Our Mission
Shriners Hospitals for Children has a mission to

Provide the highest quality care to children with neuromusculoskeletal
conditions burn injuries and other special healthcare needs within a
compassionate familycentered and collaborative care environment

Provide for the education of physicians and other healthcare professionals

Conduct research to discover new knowledge that improves the quality of care
and quality of life of children and families

This mission is carried out without regard to race color creed sex or sect disability national origin or ability of a patient or family to pay

Our Vision
Shriners Hospitals for Children will be the unquestioned leader nationally and internationally in caring for children and advancing the field in its specialty areas
NEWS
Be careful in using new information about Canadian hospitals

Thousands of Canadians every day trust their health and in some cases their lives to this countrys hospitals These patients and their families deserve as much information as possible about the care they are likely to receive and the challenges they may encounter Such transparency is the essence of an open and accountable healthcare system but Can... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More